From the T-cell receptor to cancer therapy: an interview with Tak W. Mak
- PMID: 33335286
- PMCID: PMC7745173
- DOI: 10.1038/s41418-020-00666-y
From the T-cell receptor to cancer therapy: an interview with Tak W. Mak
Abstract
This interview is part of a series of articles to mark the 25th anniversary of the launching of Cell Death and Differentiation.
Conflict of interest statement
TWM is a co-founder of Agios Pharmaceuticals, Treadwell Therapeutics and Tcryption.
Figures
References
Publication types
MeSH terms
Substances
Personal name as subject
- Actions
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
